Pancreatic Cancer Research

ResearcherJiangsu Province HospitalNo recent work listed

Shouji Cao

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5056061530. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2020: 2 papers · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper

Papers 6

  1. The SIX1/LDHA Axis Promotes Lactate Accumulation and Leads to NK Cell Dysfunction in Pancreatic Cancer. Co-author DOI 10.1155/2023/6891636↗
  2. Suppressive effect of YY1-mediated RGS22 regulation on the proliferation, migration and invasion of pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2022.13577↗
  3. Roundabout homolog 1 inhibits proliferation via the YY1-ROBO1-CCNA2-CDK2 axis in human pancreatic cancer. Co-author DOI 10.1038/s41388-021-01741-5↗
  4. DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer. Co-author DOI 10.1155/2021/6530298↗
  5. Linc01232 promotes the metastasis of pancreatic cancer by suppressing the ubiquitin-mediated degradation of HNRNPA2B1 and activating the A-Raf-induced MAPK/ERK… Co-author DOI 10.1016/j.canlet.2020.08.001↗
  6. A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosis in pancreatic cancer. Co-author DOI 10.1111/jcmm.15718↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wanli Ge · 5 shared papers, 2020–2023 · strength 0.70
  2. Kuirong Jiang · 5 shared papers, 2020–2023 · strength 0.69
  3. Lingdong Meng · 4 shared papers, 2020–2023 · strength 0.58
  4. Yi Miao · 4 shared papers, 2020–2022 · strength 0.51
  5. Qun Chen · 3 shared papers, 2020–2021 · strength 0.31
  6. Guodong Shi · 3 shared papers, 2020–2021 · strength 0.31
  7. Jingjing Zhang · 2 shared papers, 2021–2022 · strength 0.29
  8. Xumin Huang · 2 shared papers, 2020–2021 · strength 0.22
  9. Peng Shen · 2 shared papers, 2020–2021 · strength 0.22
  10. Meng Cao · 2 shared papers, 2020–2021 · strength 0.21
  11. Pengbo Zhang · 2 shared papers, 2020–2021 · strength 0.21
  12. Baobao Cai · 2 shared papers, 2020–2021 · strength 0.21
  13. Pengfei Wu · 2 shared papers, 2020 · strength 0.19
  14. Xiaole Zhu · 1 shared paper, 2023 · strength 0.18
  15. Qiang Li · 1 shared paper, 2023 · strength 0.18
  16. Yunpeng Peng · 1 shared paper, 2023 · strength 0.18
  17. Qun Chen · 1 shared paper, 2022 · strength 0.17
  18. Pengfei Wu · 1 shared paper, 2021 · strength 0.12
  19. Taoyue Yang · 1 shared paper, 2021 · strength 0.12
  20. Qun Chen · 1 shared paper, 2021 · strength 0.12
  21. Hao Yuan · 1 shared paper, 2020 · strength 0.10
  22. Kuirong Jiang · 1 shared paper, 2020 · strength 0.10
  23. Min Tu · 1 shared paper, 2020 · strength 0.10
  24. Zipeng Lu · 1 shared paper, 2020 · strength 0.09
  25. Tianfang Xia · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.